期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 59, 期 5, 页码 2192-2204出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.5b01940
关键词
-
资金
- Australian Research Council [DP140101495, FT10100185]
Fragment-based drug discovery (FBDD) is contingent on the development of analytical methods to identify weak protein fragment noncovalent interactions. Herein we have combined an underutilized fragment screening method, native state mass spectrometry, together with two proven and popular fragment screening methods, surface plasmon resonance and X-ray crystallography, in a fragment screening campaign against human carbonic anhydrase II (CA II). In an initial fragment screen against a 720-member fragment library (the CSIRO Fragment Library) seven CA II binding fragments, including a selection of nonclassical CA II binding chemotypes, were identified. A further 70 compounds that comprised the initial hit chemotypes were subsequently sourced from the full CSIRO compound collection and screened. The fragment results were extremely well correlated across the three methods. Our findings demonstrate that there is a tremendous opportunity to apply native state mass spectrometry as a complementary fragment screening method to accelerate drug discovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据